IPO Guru
Bajaj
Listed SME

Bio Medica Laboratories IPO Subscription Status

Bio Medica Laboratories IPO was subscribed 2.31 times when bidding closed on 25 May 2026: QIB 15.94x, NII 1.41x, Retail 2.92x.

The Bio Medica Laboratories IPO has been subscribed 2.31x times overall. Retail investors have shown interest with bids for 2.92x the shares available. The Non-Institutional Investor (NII) category has been subscribed 1.41x. Qualified Institutional Buyers (QIBs) have subscribed 15.94x. Data last updated on 09 Nov, 09:14 PM.

The IPO subscription period has ended. The issue opened on 21 May, 2026 and closes on 25 May, 2026. The shares are expected to list on stock exchanges on 29 May, 2026.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.

Last updated 09 Nov 2026, 09:14 PM
Category Bid details Times
QIB 5,74,000 of 36,000 15.94x
NII 24,75,000 of 17,55,000 1.41x
Retail 52,26,000 of 17,92,000 2.92x
TOTAL 82,75,000 2.31x
Advertisement

Application-wise breakup (estimated)

Approximate application counts — the exchanges don't publish these during bidding. Estimated from shares bid using the typical application size seen in recent IPOs' Basis of Allotment data. Max Applications is the number of allotment slots: one lot per retail winner, and the minimum NII application (the smallest lot count above ₹2 lakh) per sHNI and bHNI winner. Final counts appear here once the Basis of Allotment is out.

Category Est. Applied Times
Retail max 1,792 2,586 1.44x
TOTAL (EST.) 2,586

Bio Medica Laboratories IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)
1 out of 3
~34.2% chance per PAN — based on 2.92x subscription. Winners get exactly 1 lot (₹1.4 L) by SEBI lottery, however many lots you bid.
NII / HNI (above ₹2 L)
2 out of 3
~70.9% chance — lottery allots the minimum application per winner (SEBI NII rule since 2022).
QIB (institutions)
15.94x
Proportionate allotment — at 15.94x, institutions receive ~6.3% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

Subscription is above 1x, so retail allotment is by lottery. Going by the multiple alone, that is about 1 out of 3 (~34.2%) per application — an estimate; the real odds are usually better because many applicants bid for more than one lot.

Institutional Backing

Massive institutional interest with QIBs subscribing 15.94x. This often signals long-term confidence from professional funds.

Day-wise subscription history

End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.

Date Total
25 May 2026
Day 3
2.31x ▼
QIB15.94x NII1.41x Retail2.92x
22 May 2026
Day 2
1.06x ▼
QIB15.94x NII0.38x Retail1.42x
21 May 2026
Day 1
0.72x ▼
QIB15.94x NII0.03x Retail1.09x

Bio Medica Laboratories SME IPO dates

From the bidding window to listing. Today is 18 November.

Key dates Listed
  1. Open 21 May 2026
  2. Close 25 May 2026
  3. Allotment 26 May 2026
  4. Refund/credit 27 May 2026
  5. Listing 29 May 2026

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Bio Medica Laboratories IPO?

As of IPO close date (25 May, 2026), the Bio Medica Laboratories IPO is subscribed 2.31x times. Retail category is 2.92x, and NII is 1.41x subscribed.

When is the allotment date for Bio Medica Laboratories IPO?

The allotment for Bio Medica Laboratories IPO is expected to be finalized on 26 May, 2026.

What is the GMP of Bio Medica Laboratories?

The Grey Market Premium (GMP) for Bio Medica Laboratories is currently ₹2, indicating a potential listing gain of 1%.

When will Bio Medica Laboratories IPO list on the stock market?

Bio Medica Laboratories is scheduled to list on BSE and NSE on 29 May, 2026.

What are the chances of getting allotment in Bio Medica Laboratories IPO?

The retail category is oversubscribed at 2.92x, meaning allotment is by lottery. Going by the multiple alone, that is about 1 out of 3 (~34.2%) per application — an estimate; the real odds are usually better because many applicants bid for more than one lot. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 15.94x mean for Bio Medica Laboratories IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 15.94x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Bio Medica Laboratories IPO allotment status?

After the allotment date (26 May, 2026), you can check your Bio Medica Laboratories IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Bio Medica Laboratories SME IPO further

Track every stage of this IPO, from subscription to listing.

IPO Guru App
IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total
2.31x
QIB
15.94x
NII
1.41x
Retail
2.92x
Full IPO details
Advertisement